Found 16 matching trials
Pharmacokinetic Comparison of Efanesoctocog Alfa vs Other EHL-rFVIII Products in Participants With Severe Haemophilia A PHASE1 Sobi.BIVV001-003 is an open-label, 2-period, fixed sequence study for intra...
Show More Location
Sobi Investigational Site
Learn More & Join Trial
Goal Attainment and Physical Activity in People With Hemophilia A N/A This is a Phase 4, multi-center, observational study conducted in patients ...
Show More Location
Bleeding and Clotting Disorders Institute
Learn More & Join Trial
A Study to Evaluate Impact of Efanesoctocog Alfa on Long-term Joint Health in Participants With Hemophilia A in Taiwan N/A This is a national, multicenter, retrospective/prospective, observational s...
Show More Location
Investigational Site Number : 1580008
Learn More & Join Trial
Long-term Safety and Efficacy of Efanesoctocog Alfa (BIVV001) in Previously Treated Patients With Hemophilia A PHASE3 Primary Objective:
\- To evaluate the long-term safety of BIVV001 in previ...
Show More Status
Active Not Recruiting
Location
Orthopaedic Institute for Children Site Number : 8400003
Learn More & Join Trial
A Prospective Assessment of Bone Health in Patients With Severe Hemophilia A on Factor VIII vs Factor Mimetic Prophylaxis (Efa Emi Bone Health Study) N/A This study will compare bone mineral density in patients with severe hemoph...
Show More Location
Multiple Locations
Learn More & Join Trial
Pharmacokinetic Assessment of Standard Half-Life (SHL) FVIII, Extended Half-Life (EHL) FVIII, and Efanesoctocog Alfa (BIVV001) in Severe Hemophilia A PHASE1 Primary objective
• To assess the half-life of BIVV001, Standard Half-Life...
Show More Location
Investigational Site Number :1000001
Learn More & Join Trial
A Study to Evaluate Impact of Efanesoctocog Alfa on Long-term Joint Health in Participants With Hemophilia A N/A This is a prospective, observational, multi-center longitudinal cohort stud...
Show More Status
Active Not Recruiting
Location
Banner MD Anderson Cancer Center- Site Number : 8400008
Learn More & Join Trial
Study of Surgical Practices in Hemophilia A Patients Treated With Efanesoctocog Alfa (Altuvoct®) N/A Hemophilia A is an inherited bleeding disorder caused by the absence or def...
Show More Location
Unité d'Hémostase Clinique Centre Régional de Traitement des Hémophiles Centre de Référence de Maladies Hémorragiques Hôpital Cardiologique Louis Pradel
Learn More & Join Trial
Safety, Efficacy and PK of BIVV001 in Pediatric Patients With Hemophilia A PHASE3 Primary Objective:
\- To evaluate the safety of BIVV001 in previously trea...
Show More Location
Children's Hospital Los Angeles-Site Number:8400006
Learn More & Join Trial
To Assess the Pharmacokinetics and Safety and Tolerability of Efanesoctocog Alfa (BIVV001)in Adults With Type 2N and 3 Von Willebrand Disease (VWD) PHASE1 Primary Objective:
-To characterize the pharmacokinetics (PK) of BIVV001 a...
Show More Location
University of Iowa_Investigational Site Number :8400002
Learn More & Join Trial